In the Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19) published on March 9, 2020, the CDC recommends collecting both nasopharyngeal and oropharyngeal swabs from the upper respiratory system for initial diagnostic testing. If a laboratory is requested to test multiple separate specimens for the same virus, on the same patient, on the same day, how should this be reported? ...
Subscribe or sign in to view the full article.
Article Overview
This article covers CDC interim specimen-collection guidance for persons under investigation for COVID-19 and the related CPT reporting considerations when multiple separate specimens are tested for the same patient on the same day. It is useful for coders, laboratory staff, and compliance teams who need to understand the testing context, the applicable code set, and the reporting framework referenced by the article.
Why This Topic Matters
Laboratory testing for COVID-19 created frequent questions about specimen handling and how separate assays should be reported. Understanding the article helps billing and coding staff align documentation and reporting with the cited guidance.
What You Will Learn
- The specimen-collection context discussed for persons under investigation for COVID-19
- How the article frames reporting when more than one specimen is tested for the same patient on the same day
- Which coding references are tied to the laboratory testing scenario described in the article
- The role of the CDC guidance and CPT reporting context mentioned in the article
Who Should Read This
- Medical coders
- Laboratory billing staff
- Compliance professionals
- Clinical laboratory personnel
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com